Searle Company Reports Strong Growth in FY2026, Expanding Revenue and Advancing Pharmaceutical Innovation
Searle Company Strengthens Its Market Position with 29% Revenue Growth in 2026 The Searle Company...
Read More
Category: The Searle Company Limited (SEARL)
Searle Company Reports Strong Turnaround in FY2026, Declares 10% Cash Dividend
Searle Company Posts Significant Profit Growth in FY2026 The Searle Company Limited has reported a...
Read MoreSearle Subsidiary Nextar Pharma Secures Strategic Manufacturing Partnerships to Boost Growth
Searle Subsidiary Nextar Pharma Secures Strategic Manufacturing Partnerships to Boost Growth The Searle Company Limited has announced significant strategic developments involving its indirect subsidiary, Nextar Pharma (Private)...
Read MoreSearle Unveils Strategic Biopharma Expansion with PKR 4 Billion Investment Plan
The Searle Company Limited has announced a series of strategic initiatives aimed at strengthening its position in Pakistan’s growing biopharmaceutical sector. The developments, disclosed to the Pakistan Stock Exchange, reflect...
Read MoreSearle Posts 759% Surge in Nine-Month Profit as Revenue Climbs 37%
KARACHI: The Searle Company Limited reported a strong financial performance for the nine months ended March 31, 2026, posting a substantial increase in profitability driven by robust sales growth, improved margins, and...
Read More
Searle Posts Strong Q3 FY2026 Earnings, Approves Strategic Product Portfolio Restructuring
KARACHI: The Searle Company Limited reported robust financial results for the third quarter and...
Read More
Searle Explores Product Portfolio Restructuring to Drive Long-Term Growth
KARACHI: The Searle Company Limited has announced that its Board of Directors has approved the...
Read More